Cannabinoids in Experimental Stroke: A Systematic Review and Meta-Analysis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cannabinoids in Experimental Stroke: A Systematic Review and Meta-Analysis
Authors
Keywords
-
Journal
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
Volume 35, Issue 3, Pages 348-358
Publisher
SAGE Publications
Online
2014-12-10
DOI
10.1038/jcbfm.2014.218
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: Therapeutic time window, combination with t-PA and efficacy in aged rats
- (2013) Koji Murakami et al. BRAIN RESEARCH
- WIN55,212-2 protects oligodendrocyte precursor cells in stroke penumbra following permanent focal cerebral ischemia in rats
- (2012) Jing Sun et al. ACTA PHARMACOLOGICA SINICA
- Reduction of ischemic brain injury by administration of palmitoylethanolamide after transient middle cerebral artery occlusion in rats
- (2012) Akbar Ahmad et al. BRAIN RESEARCH
- WIN55, 212-2 promotes differentiation of oligodendrocyte precursor cells and improve remyelination through regulation of the phosphorylation level of the ERK 1/2 via cannabinoid receptor 1 after stroke-induced demyelination
- (2012) Jing Sun et al. BRAIN RESEARCH
- A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis
- (2012) R. M. Langford et al. JOURNAL OF NEUROLOGY
- Orally administered oleoylethanolamide protects mice from focal cerebral ischemic injury by activating peroxisome proliferator-activated receptor α
- (2012) Yu Zhou et al. NEUROPHARMACOLOGY
- Contribution of Hypothermia and CB1 Receptor Activation to Protective Effects of TAK-937, a Cannabinoid Receptor Agonist, in Rat Transient MCAO Model
- (2012) Noriko Suzuki et al. PLoS One
- Cerebroprotective effects of TAK-937, a cannabinoid receptor agonist, on ischemic brain damage in middle cerebral artery occluded rats and non-human primates
- (2011) Noriko Suzuki et al. BRAIN RESEARCH
- CB1-independent mechanisms of Δ9-THCV, AM251 and SR141716 (rimonabant)
- (2011) R. B. Raffa et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
- (2011) Mateus M Bergamaschi et al. NEUROPSYCHOPHARMACOLOGY
- Lauroylethanolamide and linoleoylethanolamide improve functional outcome in a rodent model for stroke
- (2011) Puja Garg et al. NEUROSCIENCE LETTERS
- Cannabinoid Type 2 Receptor Activation Downregulates Stroke-Induced Classic and Alternative Brain Macrophage/Microglial Activation Concomitant to Neuroprotection
- (2011) Juan G. Zarruk et al. STROKE
- Neuroprotective effect of WIN 55,212-2 pretreatment against focal cerebral ischemia through activation of extracellular signal-regulated kinases in rats
- (2010) Bo Hu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Possible Anandamide and Palmitoylethanolamide involvement in human stroke
- (2010) Marcello Naccarato et al. Lipids in Health and Disease
- A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis
- (2010) C. Collin et al. NEUROLOGICAL RESEARCH
- International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
- (2010) R. G. Pertwee et al. PHARMACOLOGICAL REVIEWS
- Combination of Tissue-Plasminogen Activator With Erythropoietin Induces Blood–Brain Barrier Permeability, Extracellular Matrix Disaggregation, and DNA Fragmentation After Focal Cerebral Ischemia in Mice
- (2010) Anil Zechariah et al. STROKE
- Publication Bias in Reports of Animal Stroke Studies Leads to Major Overstatement of Efficacy
- (2010) Emily S. Sena et al. PLOS BIOLOGY
- Therapeutic Time Window of Cannabidiol Treatment on Delayed Ischemic Damage via High-Mobility Group Box1-Inhibiting Mechanism
- (2009) Kazuhide Hayakawa et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Granulocyte-colony stimulating factor in experimental stroke and its effects on infarct size and functional outcome: A systematic review
- (2009) Timothy J. England et al. BRAIN RESEARCH REVIEWS
- Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment
- (2009) Sasidhar Murikinati et al. FASEB JOURNAL
- Modulation of effective connectivity during emotional processing by Δ9-tetrahydrocannabinol and cannabidiol
- (2009) Paolo Fusar-Poli et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injury
- (2009) Ming Zhang et al. MICROVASCULAR RESEARCH
- Intracellular mechanisms of N-acylethanolamine-mediated neuroprotection in a rat model of stroke
- (2009) P. Garg et al. NEUROSCIENCE
- Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations
- (2009) Marc Fisher et al. STROKE
- Neural Basis of Δ-9-Tetrahydrocannabinol and Cannabidiol: Effects During Response Inhibition
- (2008) Stefan J. Borgwardt et al. BIOLOGICAL PSYCHIATRY
- Endocannabinoids mediate neuroprotection after transient focal cerebral ischemia
- (2008) Markus Schomacher et al. BRAIN RESEARCH
- Cannabidiol prevents a post-ischemic injury progressively induced by cerebral ischemia via a high-mobility group box1-inhibiting mechanism
- (2008) Kazuhide Hayakawa et al. NEUROPHARMACOLOGY
- Modulation of the balance between cannabinoid CB1 and CB2 receptor activation during cerebral ischemic/reperfusion injury
- (2008) M. Zhang et al. NEUROSCIENCE
- Empirical Evidence of Bias in the Design of Experimental Stroke Studies
- (2008) Nicolas A. Crossley et al. STROKE
- Progesterone for the treatment of experimental brain injury; a systematic review
- (2007) C. L. Gibson et al. BRAIN
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started